Pro-Dex (PDEX) to Release Earnings on Thursday

Pro-Dex (NASDAQ:PDEX - Get Free Report) is expected to be issuing its Q3 2025 quarterly earnings data before the market opens on Thursday, May 1st. Analysts expect the company to announce earnings of $0.47 per share and revenue of $17.70 million for the quarter.

Pro-Dex (NASDAQ:PDEX - Get Free Report) last issued its quarterly earnings data on Thursday, January 30th. The medical instruments supplier reported $0.61 EPS for the quarter, topping the consensus estimate of $0.38 by $0.23. Pro-Dex had a net margin of 11.06% and a return on equity of 21.68%. On average, analysts expect Pro-Dex to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Pro-Dex Stock Down 3.8 %

PDEX traded down $2.60 on Tuesday, hitting $66.40. The company had a trading volume of 44,900 shares, compared to its average volume of 26,097. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.58 and a quick ratio of 1.44. Pro-Dex has a 52-week low of $16.84 and a 52-week high of $70.26. The stock has a fifty day simple moving average of $50.57 and a 200-day simple moving average of $45.09. The firm has a market capitalization of $216.53 million, a P/E ratio of 33.03 and a beta of 0.40.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded shares of Pro-Dex from a "buy" rating to a "hold" rating in a research note on Wednesday, March 12th.

Insider Buying and Selling at Pro-Dex

In other Pro-Dex news, Director Raymond E. Cabillot sold 7,674 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $45.00, for a total transaction of $345,330.00. Following the completion of the transaction, the director now owns 310,978 shares of the company's stock, valued at approximately $13,994,010. This trade represents a 2.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Over the last quarter, insiders sold 22,483 shares of company stock valued at $1,080,693. Corporate insiders own 47.50% of the company's stock.

Pro-Dex Company Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.